Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

GLAXOSMITHKLINE PLC (GSK)

147
Delayed Quote. Delayed London Stock Exchange - 10/20 08:49:49 am
1334.5 GBp   -1.48%
13m agoDJGlaxoSmithKline plc 3Q 2014 -- Forecast
6h ago GLAXOSMITHKLINE : *traders: socgen removes glaxosmithkline from 'premium li..
2d ago GLAXOSMITHKLINE : GSK update on current development status of the GSK/NIH E..
SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll news 

GlaxoSmithKline And University Of Nottingham Establish Research Center

04/26/2012 | 04:46am US/Eastern

Drug maker GlaxoSmithKline PLC (>> GlaxoSmithKline plc) and the University of Nottingham said Thursday that they formalized a collaboration to establish a new laboratory to accommodate the Centre of Excellence for sustainable chemistry and to construct an innovative carbon neutral sustainable chemistry laboratory.

MAIN FACTS:

-The Laboratory for Sustainable Chemistry is being supported by a GBP12 million grant from Glaxo.

-Shares at 0829 GMT, down 10 pence, or 0.71%, at 1,403.5 pence valuing the company at GBP71.28 million.

-By Rory Gallivan, Dow Jones Newswires; 44-20-7842-9411; rory.gallivan@dowjones.com

Stocks mentioned in the article : GlaxoSmithKline plc
Latest news on GLAXOSMITHKLINE PLC
13m agoDJGlaxoSmithKline plc 3Q 2014 -- Forecast
6h ago GLAXOSMITHKLINE : *traders: socgen removes glaxosmithkline from 'premium list'
2d ago GLAXOSMITHKLINE : GSK update on current development status of the GSK/NIH Ebola ..
3d agoGLAXOSMITHKLINE PLC : quaterly earnings release
3d ago GLAXOSMITHKLINE : PRESS: Glaxo's Ebola Drug To "Come Too Late" For Current Outbr..
3d ago GLAXOSMITHKLINE : Glaxo Gets Positive Results For Anoro Ellipta COPD Treatment
3d ago GLAXOSMITHKLINE : Data published on Anoro® Ellipta® demonstrate improved lung fu..
4d ago GLAXOSMITHKLINE : *barclays cuts glaxosmithkline price target to 1485 pence - 'e..
6d ago GLAXOSMITHKLINE : New market study, "Vitamins and Dietary Supplements in Germany..
6d ago GLAXOSMITHKLINE : DIRECTOR DEALINGS: Glaxo Directors, Managers Reinvest Dividend..
Advertisement
Chart
Duration : Period :
GlaxoSmithKline plc Technical Analysis Chart | GSK | GB0009252882 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF